University of Central Lancashire
Preston, Lancashire, PR1 2HE, United Kingdom
NCT Number: NCT05133700
To describe the barriers and facilitators experienced by residents, health and social care staff, commissioners and regulators when managing medicines within care homes.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Preston, Lancashire, PR1 2HE, United Kingdom
The prescribing of medicines is the most frequent health intervention in England. The administration or omission of medicines is not without risk and incidents involving medicines occur. The frequency of prescribing medicines increases with age and frailty. People living in care homes (with and without nursing) are generally older and more frail than similar groups in the community. Therefore, care homes and their staff need to be proficient and safe when administering medicines.
However, an under investigated area of prescribed medicines is the views of people living in care homes, health and social care staff, commissioners and regulator about managing medicines in care homes.
During the study a series of semi-structured interviews and focus groups will be undertaken. These focus groups will be held with people living in care homes (with and without nursing). Further interviews and focus groups will be held with health and social care staff, commissioners and regulators.
Care homes will be invited to provide copies of their current medicines monitoring tool. In addition, services supporting care homes including community pharmacies will also be invited to provide copies of their current medicines monitoring tools.
Analysis of conversations and monitoring tools made available to the study team will be undertaken and compared to published literature including grey literature.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
There is no intervention. This is a qualitative piece of work only
There is no intervention. This is a qualitative piece of work only
Time frame: 0 to 9 months
Transcribed interviews will be coded and then emerging themes from the data identified and developed. A constant comparison method of analysis will be used. The presence or lack of consensus and reinforcement on certain topics will also be observed.
Time frame: 0 to 9 months
Transcribed focus groups will be coded and then emerging themes from the data identified and developed. A constant comparison method of analysis will be used. The presence or lack of consensus and reinforcement on certain topics will also be observed.
Time frame: 9 to 12 months
Current medicines monitoring tools will be coded and then emerging themes from the data identified and developed. A constant comparison method of analysis will be used. The presence or lack of consensus and reinforcement on certain topics will also be observed.
Time frame: 9 to 12 months
Themes and topics that emerged from the interviews, focus groups and current medicines monitoring tools will be compared and contrasted with each other and the evidence identified from a separate scoping review.
University of Central Lancashire
Other
Use and Opinions' Concerning Medicines Related Errors, Monitoring and Audit Tools Used to Assess Medicines Optimisation Within Care Homes in England
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03799367
Behavior, Breast Feeding
Cambridge, United Kingdom
View Trial DetailsNCT00439348
Behavior, Drugs, Non-Prescription
Orlando, Florida, United States
View Trial DetailsNCT07298694
Cardiovascular Diseases, Choice Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT07460219
Cardiovascular Diseases, Heart Diseases
Palo Alto, California, United States
View Trial Details